Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

No longer available × Powders × 90 days × Clear all

Status

No longer available 2 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Expanded_access 2

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1

Conditions

Urogenital Neoplasms 1 Prostatic Neoplasms 1 Lung Neoplasms 1

Interventions

Suspensions 2 Powders 2 taletrectinib 1 capmatinib 1 asparaginase erwinia chrysanthemi recombinant 1 Paclitaxel 1 HMPL-013 1 Docetaxel 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03756311 2026-01-23

Expanded Access to NanoPac

NanOlogy, LLC

No longer available

GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

NCT04060628 2026-01-23

Expanded Access to NanoDoce

NanOlogy, LLC

No longer available

Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡